Arbutus Biopharma

In News

Arbutus Biopharma (ABUS) Q3 Loss And Revenue Drop Challenge Bullish Profitability Narratives - simplywall.st

simplywall.st - Mar 23, 2026

Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna - GlobeNewswire

GlobeNewswire - Mar 03, 2026

ABUS Should I Buy - intellectia.ai

intellectia.ai - Mar 31, 2026

Moderna settlement reshapes Arbutus Biopharma (ABUS) with $950M payout - Stock Titan

Stock Titan - Mar 23, 2026

Arbutus Biopharma Corp reports results for the quarter ended December 31 - Earnings Summary - tradingview.com

tradingview.com - Mar 25, 2026

Arbutus: Q4 Earnings Snapshot - WWLTV.com

WWLTV.com - Mar 23, 2026

Arbutus Biopharma: LNP Litigation And Imdusiran Drive Near-Term Catalysts (NASDAQ:ABUS) - seekingalpha.com

seekingalpha.com - Feb 03, 2026

Moderna Settles with Genevant and Arbutus, Ending LNP Patent Dispute - IPWatchdog.com

IPWatchdog.com - Mar 04, 2026

Judge Wolson Issues Key Summary Judgment Ruling on the Eve of Trial in the Arbutus v. Moderna mRNA Vaccine and Lipid Nanoparticle Case | Rothwell, Figg, Ernst & Manbeck, P.C. - JD Supra

JD Supra - Feb 05, 2026

Court Rejects Two Moderna Defenses in mRNA Vaccine Patent Row With Arbutus - BioSpace

BioSpace - Feb 18, 2026

Arbutus Biopharma 2025 Financials: Reduced Annual Loss, Revenue Growth - News and Statistics - indexbox.io

indexbox.io - Mar 23, 2026

Chardan reiterates Arbutus Biopharma stock rating on Moderna deal - Investing.com

Investing.com - Mar 04, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment